Dr. Germain's CV
Marguerite Ann Germain, M.D.
1993: University of Maryland School of Medicine, Baltimore, MD – Doctor of Medicine
1989: University of Maryland, Catonsville, MD; B.A., Biological Sciences (summa cum laude)
POST GRADUATE TRAINING
April, 2004 to Present: Attending Physician, Department of Dermatology, Medical University of South Carolina (MUSC)
2000: Residency, dermatology, National Capital Consortium (National Naval Medical Center, Bethesda, MD and Walter Reed Army Medical Center, Washington, DC)
1995: Navy Flight Surgery, Naval Aerospace and Operational Medical Institute, Pensacola, FL
1994: Internship, Internal Medicine, National Naval Medical Center, Bethesda, MD
March, 2003 to Present: Private Practice, Germain Dermatology Associates, PA, Mt. Pleasant, SC
October, 2002 to February, 2003: Staff Dermatologist, Naval Hospital, Charleston, SC (Employed through MED-STAFF Medical Staffing)
July, 2000 to October, 2002: Head, Department of Dermatology, Naval Hospital, Charleston, SC
July, 1995 to June, 1997: Flight Surgeon, Naval Air Station, Dallas, TX
June, 1994 to January, 1995: General Medical Officer, National Naval Medical Center, Dept. of Military Medicine, Bethesda, MD
NATIONAL TRAINING CENTER
Dermik (Sculptra), Candela Lasers
CONSULTANT AND SPEAKERS BUREAU
Amgen, Biogen, Novartis, CollaGenex, 3M, Dermik, Candela Laser , Stiefel
SPEAKERS BUREAU ONLY
Allergan, Burroughs Wellcome
- Fellow, American Academy of Dermatology
- Fellow, American Society for Mohs Surgery
- Women's Dermatological Society
- South Carolina Medical Association
- South Carolina Dermatological Society
- American Society for Dermatologic Surgery
- American Society of Cosmetic Dermatology and Aesthetic Surgery
- American Society for Laser Medicine and Surgery
- International Society of Cosmetic and Laser Surgeons
- Society of Navy Flight Surgeons
STATE LICENSURE & CERTIFICATION
Medical License: South Carolina
Current BLS, ACLS
Current DEA Registration
"Topical 5% imiquimod for the therapy of actinic cheilitis." J Am Acad Dermatol 2002 Oct;47(4):497-501
"Therapy of Bowen's disease in transplant patients with imiquimod and 5% 5FU" Dermatol Surg. 2001 Jun; 27(6):561-4.
"CD34 + Cellular Blue Nevi" J Cutan Path. 2001 Mar; 28(3);145-50.
"Treatment of Bowen's disease in immune suppressed patients with imiquimod and COX inhibitors" Dermatol Surg. 2001 Feb; 27(2):143-6.
"Smoldering HTLV- I -induced T-cell lymphoma localized within the skin; a radiation-resistant tumor" Int J Dermatol. 2000 Nov; 39(11):815-2 1.
"The cutaneous cellular infiltrate to stingray envenomization contains increased TIA + cells" Br J Dermatol.2000 Nov; 143(5):1074-7.
"Telomerase: carcinogenesis and aging, Part 11" Cosmetic Dermatology. 2000 Feb.
"Telomerase: carcinogenesis and aging, Part I" Cosmetic Dermatology. 2000 Jan.
"Perspectives in Dermatolpathology: telomeres and telomerase in aging and cancer; with emphasis on cutaneous disease" J Cutan Path. 2000 Jan; 27(l):2-18. Review.
"Increased soft tissue in the posterior' cervical and upper back area of patients on HIV- I protease inhibitors" J Cutan Med Surg. 1999 Apr: 3(4).211- 7.
"Follicular hamartoma in a newborn" J Am Acad Dermatol.
"Post-vaccination herpes zoster in a 20 month old child" J Am Acad Dermatol